Financial Gravity Asset Management, Inc. Galectin Therapeutics Inc Transaction History
Financial Gravity Asset Management, Inc.
- $459 Billion
- Q1 2025
A detailed history of Financial Gravity Asset Management, Inc. transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Financial Gravity Asset Management, Inc. holds 5,997 shares of GALT stock, worth $7,736. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,997Holding current value
$7,736% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GALT
# of Institutions
113Shares Held
10MCall Options Held
3.78MPut Options Held
5.27M-
Vanguard Group Inc Valley Forge, PA2.14MShares$2.76 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$2.02 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.18MShares$1.52 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA871KShares$1.12 Million0.0% of portfolio
-
Wealthspire Advisors, LLC New York, NY398KShares$513,9020.0% of portfolio
About GALECTIN THERAPEUTICS INC
- Ticker GALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,426,000
- Market Cap $76.7M
- Description
- Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...